In contrast, a slight trend in increased CRP was observed with increasing E2 and FE2 levels. These figures show an inverse association of CRP levels with both TT and SHBG. Figure 1 presents scatterplots of CRP against sex hormone levels (TT, SHBG, and E2). Descriptive statistics for sex hormones and C-reactive protein (CRP) levels. Characteristics of the men included in the analysis are presented in Table 1 and descriptive statistics on sex hormones and CRP levels are included in Table 2. Multiple linear regression models were used to assess the association between sex hormones and CRP and to adjust for potential confounders. This antigen-antibody complex causes an increase in light scattering, which is detected spectrophotometrically, with the magnitude of the change being proportional to the concentration of CRP in the sample. This is a methodological challenge for all long-term observational studies investigating the changes in sex hormones. However, residual confounding cannot be excluded due to the observational nature of the study. This is a large cohort-based study of men, representative of the population in Sweden. This change in estimates was larger in the cross-sectional analyses than in the longitudinal ones (Table 3). To the best of our knowledge, no studies have examined a longitudinal association between high CRP concentration and the development of hypogonadism. It has previously been observed that testosterone, through its androgen receptors, regulates the expression of cytokines, providing a modulating role in the inflammatory response (2, 7). Testosterone concentration decreases with aging, and if reaching hypogonadic levels in adulthood, this is defined as late-onset hypogonadism (LOH), according to the European Association of Urology (EAU) (5). Serum concentrations of testosterone and C-reactive protein (CRP) were measured at both visits. Although, in this study, even though the prevalence of T2D and hypertension increased during follow-up time, the association remained statistically significant (data not shown). Another strength of the study was the standardized sampling of blood specimens in the morning after fasting according to EAU guidelines, avoiding diurnal changes in the levels of sex hormones (5, 6, 37, 38). Although a large part of the cohort could not participate in this study due to loss-to-follow-up, sensitivity analyses showed similar characteristics between participants and non-participants at the second visit. In a cross-sectional study on Finnish non-diabetic men (1896 participants), results suggested metabolic syndrome as a great contributor to the high CRP–low testosterone relationship (21). Moreover, our data indicate that CRP, a marker of inflammation, per se can predict the development of biochemical hypogonadism regardless of anthropometric measures such as WHR and BMI. The magnitude of the effect was observed to be lower when adjusting for BMI in all fully adjusted models although the same direction in the association was observed (data not shown). When assessing the relationship between hsCRP levels and biochemical hypogonadism, similar models were used (Table 3). The concentration of CRP was determined using an immunoturbidimetric assay on the Hitachi 917 analyzer (Roche Diagnostics - Indianapolis, IN), using reagents and calibrators from DiaSorin (Stillwater, MN). The inter-assay CVs for E2 concentrations 4.6–220 pmol/L (1.25–60 pg/mL) ranged between 13.4–6.0%. To reliably measure E2 levels in the low range, E2 values less than 46 pmol/L (12.5 pg/mL) were calculated by manual integration of chromatograms. The inter-assay coefficients of variation (CV) for T at concentrations of 0.8, 9.5 and 24.3 nmol/L (24, 275, and 700 ng/dL) were 7.4, 2.2, and 1.7%, respectively. However, comparison of sociodemographic and health-related variables from BACH with other large regional (Boston Behavioral Risk Factor Surveillance System) and national (National Health Interview Survey) surveys have shown that the BACH estimates are comparable to national trends on key health related variables. History of comorbid conditions was assessed by self-report with the potential for reporting and/or recall bias; however, previous research has demonstrated the reliability and validity of self-report for heart disease, diabetes, and hypertension.30 The BACH study was limited geographically to the Boston area. However, a full analysis of the potential influence of medication use in general on CRP levels is beyond the scope of this paper. Thus, we cannot exclude the alternative hypothesis that low androgen levels may be a consequence of inflammation. Over half of the analysis sample reported use of anti-inflammatory or other medications that could affect CRP levels. Analyses were conducted on a sample of 1,559 men with complete data on sex hormones and CRP. Serum testosterone (T) and sex hormone-binding globulin (SHBG) levels were measured by competitive electrochemiluminescence immunoassays on the 2010 Elecsys system (Roche Diagnostics, Indianapolis, IN). A robust, inverse dose-response correlation between testosterone and SHBG levels with CRP levels provides further evidence of a potential role of androgens in inflammatory processes. The association between CRP and sex hormone levels was assessed using multiple linear regression models.